Good Quality Raw Material Antiestrogenfaslodex (CAS: 129453-61-8)
-
Post Date:
Jul 26,2017
-
Expiry Date:
Jan 22,2018
-
Detailed Description:
Cas No. :129453-61-8
Quantity: 500Kilograms
Price:2000 USD Kilograms
Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.
Faslode is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.
Fulvestrante is a selective estrogen receptor down-regulator (SERD). Fulvestrante is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. The dosing schedule for fulvestrante remains under investigation in an attempt to optimize its effectiveness.Email : anabolic@sinosteroids.com
Website : www.sinosteroids.com
Tel : +8617076116742
-
CAS Registry Number:
129453-61-8
-
Synonyms:
;(7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;(7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol;(17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol;Faslodex;
-
Molecular Formula:
C32H47F5O3S
-
Molecular Weight:
606.7708
-
Molecular Structure:
-
Company:
HongKong Blue Universal Co., Limited.
[ China ]
-
Contact:
Henry
-
Tel:
+86-170-76116742
-
Fax:
86-170-76116742
-
Email:
anabolic@sinosteroids.com
Inquiry